Want to join the conversation?
$CELG affirmed its 2020 long-term financial targets of net products sales exceeding $21Bil, with Hematology franchise to exceed $14.8Bil, Oncology franchise to exceed $2.2Bil, and I&I franchise to exceed $4Bil. Adjusted EPS is projected to exceed $13.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?